Junctional epidermolysis bullosa

From WikiMD's WELLNESSPEDIA

(Redirected from Herlitz disease)

Junctional epidermolysis bullosa (JEB) is a rare genetic disorder that affects the skin and mucous membranes. It is characterized by blister formation within the lamina lucida of the basement membrane zone.

Signs and Symptoms[edit]

The primary symptom of JEB is the formation of blisters on the skin and mucous membranes. These blisters can be caused by minor trauma or friction, such as rubbing or scratching. Other symptoms can include hair loss, dental problems, difficulty swallowing, and respiratory problems.

Causes[edit]

JEB is caused by mutations in the genes that encode for the proteins laminin-332 and type XVII collagen. These proteins are essential for the proper formation and functioning of the skin and mucous membranes. Without these proteins, the skin and mucous membranes are more susceptible to damage and blister formation.

Diagnosis[edit]

The diagnosis of JEB is typically made based on the clinical presentation of the patient, including the presence of blisters on the skin and mucous membranes. Genetic testing can confirm the diagnosis and identify the specific gene mutation causing the disease.

Treatment[edit]

There is currently no cure for JEB. Treatment is focused on managing the symptoms and preventing complications. This can include wound care, pain management, nutritional support, and in some cases, surgical intervention.

Prognosis[edit]

The prognosis for individuals with JEB varies depending on the severity of the disease. Some forms of JEB are lethal in infancy, while others are associated with a normal lifespan but significant morbidity.

See Also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.